AI in Medicine: Opportunities, Limitations, and What the Evidence Actually Shows
If you follow AI news in medicine, you could be forgiven for thinking the field is simultaneously on the verge of curing everything and about to cause catastrophic harm. Both camps are overstating their case.
The honest picture is more interesting and more useful than either extreme. AI is producing real value in specific, well-defined clinical tasks. It is underperforming expectations in others. And in some areas, the evidence base is too thin to draw meaningful conclusions yet. This course gives you the framework to tell the difference.
Where the evidence for AI in medicine is actually strongest
The strongest clinical evidence for AI performance is in image analysis tasks with clear, well-defined endpoints. Radiology leads the field. AI systems have matched or exceeded radiologist performance in detecting specific findings in mammography screening, identifying diabetic retinopathy from fundus photographs, classifying skin lesions from dermoscopic images, and detecting certain patterns on chest radiographs.
The operative phrase in every one of those examples is controlled study conditions. Performance in carefully curated validation datasets is consistently better than performance in real-world clinical environments. The gap between benchmark performance and real-world performance is one of the most important and most underreported facts in medical AI research. When you read a study claiming impressive AI diagnostic accuracy, the first question to ask is: what does this look like outside the validation set?
